News
-
Public Consultation for ICH Guideline M14 launched in Switzerland
-
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 July 2024
-
Decision C-2510/2021, C-2513/2021 of 12 June 2024
-
The European Pharmacopoeia Abolishes Rabbit Testing
-
Decision C-5859/2023 of 29 May 2024
-
Decision 2C_172/2024 of 27 May 2024
-
Price Changes for Certain Medicinal Products
-
Swissmedic Journal 06/2024
-
Warning about Supposedly Herbal Products
-
Update to the Forms: New Authorisation of Human Medicinal Products and Variations and Authorisation Extensions HAM
-
Update of TPLRO and TPLO Annexes
-
COVID-19 Ordinance 3 Ceases to Apply on 30 June 2024
-
Addendum 11.5 of the European Pharmacopoeia in Force
-
Standardization of Practice on Publication of Indications in SwissPAR
-
Fee Reduction for Non-Commercial Clinical Trials
-
Meeting Highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 June 2024
-
Decision 9C_169/2023 of 29 May 2024
-
Strengthening Measures Against Antibiotic Resistance
-
Go-live for the Swissdamed Actors Module
-
EU Actions to Address GLP-1 Receptor Agonist Shortages
-
Decision B-468/2022 of 11 June 2024